Raymond James & Associates’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $94.4K | Sell |
15,368
-6,623
| -30% | -$40.7K | ﹤0.01% | 3747 |
|
|
2024
Q2 | $146K | Sell |
21,991
-99,146
| -82% | -$659K | ﹤0.01% | 3635 |
|
|
2024
Q1 | $1.23M | Buy |
+121,137
| New | +$1.23M | ﹤0.01% | 2458 |
|
|
2022
Q4 | – | Sell |
-31,710
| Closed | -$405K | – | 3780 |
|
|
2022
Q3 | $405K | Buy |
+31,710
| New | +$405K | ﹤0.01% | 2977 |
|
|
2021
Q3 | – | Sell |
-11,786
| Closed | -$116K | – | 3933 |
|
|
2021
Q2 | $116K | Buy |
+11,786
| New | +$116K | ﹤0.01% | 3762 |
|
|
2018
Q3 | – | Sell |
-1,486
| Closed | -$20K | – | 3498 |
|
|
2018
Q2 | $20K | Buy |
1,486
+230
| +18% | +$3.1K | ﹤0.01% | 3433 |
|
|
2018
Q1 | $44K | Buy |
+1,256
| New | +$44K | ﹤0.01% | 3287 |
|